• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于数据驱动的急性 SARS-CoV-2 感染后亚表型识别。

Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.

机构信息

Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.

Department of Health Outcomes Biomedical Informatics, University of Florida, Gainesville, FL, USA.

出版信息

Nat Med. 2023 Jan;29(1):226-235. doi: 10.1038/s41591-022-02116-3. Epub 2022 Dec 1.

DOI:10.1038/s41591-022-02116-3
PMID:36456834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9873564/
Abstract

The post-acute sequelae of SARS-CoV-2 infection (PASC) refers to a broad spectrum of symptoms and signs that are persistent, exacerbated or newly incident in the period after acute SARS-CoV-2 infection. Most studies have examined these conditions individually without providing evidence on co-occurring conditions. In this study, we leveraged the electronic health record data of two large cohorts, INSIGHT and OneFlorida+, from the national Patient-Centered Clinical Research Network. We created a development cohort from INSIGHT and a validation cohort from OneFlorida+ including 20,881 and 13,724 patients, respectively, who were SARS-CoV-2 infected, and we investigated their newly incident diagnoses 30-180 days after a documented SARS-CoV-2 infection. Through machine learning analysis of over 137 symptoms and conditions, we identified four reproducible PASC subphenotypes, dominated by cardiac and renal (including 33.75% and 25.43% of the patients in the development and validation cohorts); respiratory, sleep and anxiety (32.75% and 38.48%); musculoskeletal and nervous system (23.37% and 23.35%); and digestive and respiratory system (10.14% and 12.74%) sequelae. These subphenotypes were associated with distinct patient demographics, underlying conditions before SARS-CoV-2 infection and acute infection phase severity. Our study provides insights into the heterogeneity of PASC and may inform stratified decision-making in the management of PASC conditions.

摘要

SARS-CoV-2 感染的急性后期后遗症(PASC)是指在急性 SARS-CoV-2 感染后持续存在、加重或新出现的广泛症状和体征。大多数研究都单独检查了这些情况,没有提供同时存在的情况的证据。在这项研究中,我们利用了来自国家以患者为中心的临床研究网络的两个大型队列 INSIGHT 和 OneFlorida+ 的电子健康记录数据。我们从 INSIGHT 创建了一个开发队列,从 OneFlorida+ 创建了一个验证队列,分别包括 20881 名和 13724 名 SARS-CoV-2 感染患者,我们调查了他们在有记录的 SARS-CoV-2 感染后 30-180 天新出现的诊断。通过对超过 137 种症状和疾病的机器学习分析,我们确定了四个可重复的 PASC 亚表型,主要由心脏和肾脏(分别占发展和验证队列患者的 33.75%和 25.43%)、呼吸、睡眠和焦虑(32.75%和 38.48%)、肌肉骨骼和神经系统(23.37%和 23.35%)以及消化和呼吸系统(10.14%和 12.74%)后遗症主导。这些亚表型与不同的患者人口统计学特征、SARS-CoV-2 感染前的基础疾病和急性感染阶段的严重程度有关。我们的研究提供了对 PASC 异质性的深入了解,并可能为 PASC 疾病的分层决策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/80f0fee07eeb/41591_2022_2116_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/7a8b02e64560/41591_2022_2116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/42de72f5af81/41591_2022_2116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/67778af52577/41591_2022_2116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/077195ba925e/41591_2022_2116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/1e5267ebd454/41591_2022_2116_Fig5_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/39ae0745e28f/41591_2022_2116_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/397535e17b08/41591_2022_2116_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/fe122634d6b1/41591_2022_2116_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/dd4e16be6c96/41591_2022_2116_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/ca7676827ddc/41591_2022_2116_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/8f493707f088/41591_2022_2116_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/597e477c84dd/41591_2022_2116_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/447120a4ad05/41591_2022_2116_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/80f0fee07eeb/41591_2022_2116_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/7a8b02e64560/41591_2022_2116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/42de72f5af81/41591_2022_2116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/67778af52577/41591_2022_2116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/077195ba925e/41591_2022_2116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/1e5267ebd454/41591_2022_2116_Fig5_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/39ae0745e28f/41591_2022_2116_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/397535e17b08/41591_2022_2116_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/fe122634d6b1/41591_2022_2116_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/dd4e16be6c96/41591_2022_2116_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/ca7676827ddc/41591_2022_2116_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/8f493707f088/41591_2022_2116_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/597e477c84dd/41591_2022_2116_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/447120a4ad05/41591_2022_2116_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/956e/9873564/80f0fee07eeb/41591_2022_2116_Fig14_ESM.jpg

相似文献

1
Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.基于数据驱动的急性 SARS-CoV-2 感染后亚表型识别。
Nat Med. 2023 Jan;29(1):226-235. doi: 10.1038/s41591-022-02116-3. Epub 2022 Dec 1.
2
Machine Learning for Identifying Data-Driven Subphenotypes of Incident Post-Acute SARS-CoV-2 Infection Conditions with Large Scale Electronic Health Records: Findings from the RECOVER Initiative.利用机器学习通过大规模电子健康记录识别急性后SARS-CoV-2感染事件的数据驱动亚表型:RECOVER计划的发现。
medRxiv. 2022 Jun 8:2022.05.21.22275412. doi: 10.1101/2022.05.21.22275412.
3
A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.SARS-CoV-2 生物库的纵向研究,用于 COVID-19 幸存者,包括有无急性后期后遗症。
BMC Infect Dis. 2021 Jul 13;21(1):677. doi: 10.1186/s12879-021-06359-2.
4
Neurological post-acute sequelae of SARS-CoV-2 infection.新型冠状病毒感染的神经后急性后遗症。
Psychiatry Clin Neurosci. 2023 Feb;77(2):72-83. doi: 10.1111/pcn.13481. Epub 2022 Oct 17.
5
Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative.基于 RECOVER 计划电子健康记录的分析:与新冠病毒疾病前阻塞性睡眠呼吸暂停诊断相关的 SARS-CoV-2 感染后急性后遗症风险。
Sleep. 2023 Sep 8;46(9). doi: 10.1093/sleep/zsad126.
6
Risk Factors and Predictive Modeling for Post-Acute Sequelae of SARS-CoV-2 Infection: Findings from EHR Cohorts of the RECOVER Initiative.新冠病毒感染后急性后遗症的风险因素及预测模型:RECOVER计划电子健康记录队列研究结果
Res Sq. 2023 Mar 8:rs.3.rs-2592194. doi: 10.21203/rs.3.rs-2592194/v1.
7
Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis.长新冠患者自我报告症状和结局的亚表型:一项采用潜在类别分析的前瞻性队列研究。
BMJ Open. 2024 Mar 14;14(3):e077869. doi: 10.1136/bmjopen-2023-077869.
8
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).COVID-19 病理学和 SARS-CoV-2 感染后后遗症(PASC)的免疫机制。
Elife. 2023 May 26;12:e86014. doi: 10.7554/eLife.86014.
9
Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative.利用 RECOVER 计划中的电子健康记录进行数据驱动分析以了解长新冠。
Nat Commun. 2023 Apr 7;14(1):1948. doi: 10.1038/s41467-023-37653-z.
10
Pre-existing conditions associated with post-acute sequelae of COVID-19.与 COVID-19 后急性后遗症相关的既往疾病。
J Autoimmun. 2023 Feb;135:102991. doi: 10.1016/j.jaut.2022.102991. Epub 2023 Jan 6.

引用本文的文献

1
Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins.新冠后遗症期间持续的免疫失调表现为针对包膜蛋白和核衣壳蛋白的抗体。
bioRxiv. 2025 Aug 19:2025.08.18.670908. doi: 10.1101/2025.08.18.670908.
2
Immunization as Protection Against Long COVID in the Americas: A Scoping Review.免疫接种作为美洲预防长期新冠的手段:一项范围综述
Vaccines (Basel). 2025 Jul 31;13(8):822. doi: 10.3390/vaccines13080822.
3
Long COVID risk by pre-infection symptoms and functional status: A retrospective cohort study of data from the Research Program.
感染前症状和功能状态与长期新冠风险:基于研究项目数据的回顾性队列研究
medRxiv. 2025 Aug 12:2025.08.07.25333259. doi: 10.1101/2025.08.07.25333259.
4
From Stagnation to Strategy: Challenges in Advancing Long COVID Research.从停滞到战略:推进长新冠研究面临的挑战
J Eval Clin Pract. 2025 Aug;31(5):e70180. doi: 10.1111/jep.70180.
5
Persistence of symptoms in long-COVID: follow-up trajectories of 30 symptoms in 755 patients from a national multicenter study from Italy.长期新冠症状的持续存在:来自意大利一项全国多中心研究的755名患者中30种症状的随访轨迹
Intern Emerg Med. 2025 Jul 22. doi: 10.1007/s11739-025-04051-w.
6
Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms.抗SARS-CoV-2抗体反应对重要器官相关的长期新冠症状的保护作用。
Sci Rep. 2025 Jul 3;15(1):23705. doi: 10.1038/s41598-025-04152-8.
7
Comparison of long COVID, recovered COVID, and non-COVID Post-Acute Infection Syndromes over three years.三年来长新冠、新冠康复者及非新冠急性感染后综合征的比较。
PLoS One. 2025 May 20;20(5):e0323104. doi: 10.1371/journal.pone.0323104. eCollection 2025.
8
Identification of predictive subphenotypes for clinical outcomes using real world data and machine learning.利用真实世界数据和机器学习识别临床结局的预测性子表型。
Nat Commun. 2025 May 12;16(1):3797. doi: 10.1038/s41467-025-59092-8.
9
Using machine learning involving diagnoses and medications as a risk prediction tool for post-acute sequelae of COVID-19 (PASC) in primary care.在初级医疗保健中,将涉及诊断和药物治疗的机器学习作为新冠后急性后遗症(PASC)的风险预测工具。
BMC Med. 2025 Apr 30;23(1):251. doi: 10.1186/s12916-025-04050-w.
10
Trajectories of persisting Covid- 19 symptoms up to 24 months after acute infection: findings from the Predi-Covid cohort study.急性感染后长达24个月的持续性新冠症状轨迹:Predi-Covid队列研究的结果
BMC Infect Dis. 2025 Apr 25;25(1):603. doi: 10.1186/s12879-025-11023-0.